Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MiRNA expression profile in breast cancer cells

ABSTRACT: miRNA expression profile in breast cancer cells

PROVIDER: PRJEB4982 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR372263.fastq.gz	Fastqsanger.gz
	ERR372264.fastq.gz	Fastqsanger.gz
	ERR372265.fastq.gz	Fastqsanger.gz
	ERR372266.fastq.gz	Fastqsanger.gz
	ERR372267.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

miRNA expression profile in breast cancer cells

Project description:miRNA expression profile in breast cancer cells

| PRJEB4983 | ENA

miRNA expression profile in breast cancer cells

Project description:miRNA expression profile in breast cancer cells

| PRJEB1420 | ENA

Gene expression profile in breast cancer cells

Project description:Gene expression profile in breast cancer cells

| PRJNA447896 | ENA

miRNA profile of single hormone receptor positive breast cancer patients

Project description:miRNA profile of single hormone receptor positive breast cancer patients

| PRJNA649524 | ENA

Breast Cancer Cell Secretome Analysis to Decipher miRNA Tumor Biology and Discover Potential Biomarkers

Project description:MicroRNA (miRNA/miR) miR526b and miR655 overexpressed tumor cell-free secretions promote breast cancer phenotypes in the tumor microenvironment (TME). However, the mechanisms of miRNA regulating TME have never been investigated. With mass spectrometry analysis of MCF7-miRNA-overexpressed versus miRNA-low MCF7-Mock tumor cell secretomes, we identified 34 novel secretory proteins coded by eight genes YWHAB, TXNDC12, MYL6B, SFN, FN1, PSMB6, PRDX4, and PEA15 those are differentially regulated. We used bioinformatic tools and systems biology approaches to identify these markers’ role in breast cancer. Gene ontology analysis showed that the top functions are related to apoptosis, oxidative stress, membrane transport, and motility, supporting miRNA-induced phenotypes. These secretory markers expression is high in breast tumors, and a strong positive correlation exists between upregulated markers’ mRNA expressions with miRNA cluster expression in luminal A breast tumors. Gene expression of secretome markers is higher in tumor tissues compared to normal samples, and immunohistochemistry data supported gene expression data. Moreover, both up and downregulated marker expressions are associated with breast cancer patient survival. miRNA regulates these marker protein expressions by targeting transcription factors of these genes. Premature miRNA (pri-miR526b and pri-miR655) are established breast cancer blood biomarkers. Here we report novel secretory markers upregulated by miR526b and miR655 (YWHAB, MYL6B, PSMB6, and PEA15) are significantly upregulated in breast cancer patients’ plasma, and are potential breast cancer biomarkers.

2023-05-10 | PXD031771 | Pride

miRNA expression profiling in early stage breast cancer

Project description:MiRNA profiling from whole blood (EDTA) was used to identify a miRNA profile applicable for early stage breast cancer detection

2012-02-02 | GSE31309 | GEO

miRNA expression in breast cancer cell lines

Project description:miRNA expression in breast cancer cell lines

| PRJNA497259 | ENA

miRNA expression profiling in early stage breast cancer

Project description:MiRNA profiling from whole blood (EDTA) was used to identify a miRNA profile applicable for early stage breast cancer detection In the study presented here, a consecutively collected, well-defined cohort of 48 patients with early stage breast cancer (invasive ductal carcinoma) at diagnosis was compared with a cohort of 57 healthy individuals for known homo sapiens miRNAs (mirbase 15).

2012-02-02 | E-GEOD-31309 | biostudies-arrayexpress

profile miRNA expression in breast cancer

Project description:differential miRNA expression between breast tumor tissue and normal tissue

2014-02-01 | GSE44124 | GEO

miRNA expression in breast cancer cell lines

Project description:We analyzed the miRNA expression in 6 breast cancer cell lines from young (HCC1500, HCC1937) and old (MCF-7, MDA-MB-231, HCC1806 and MDA-MB-468) patients with breast cancer using the GeneChip® miRNA 2.0 Array (Affymetrix, Santa Clara, CA, USA).

2020-04-16 | GSE121396 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data